Side-by-side comparison of AI visibility scores, market position, and capabilities
Modern cloud-native EHR for direct primary care and value-based care organizations; API-first architecture replacing legacy systems competing with athenahealth and Elation Health.
Canvas Medical is a cloud-native electronic health record (EHR) platform designed specifically for modern primary care practices — combining clinical documentation (notes, orders, prescriptions), care management (population health tracking, chronic disease programs, care gap identification), billing and revenue cycle, and patient communication in an integrated system built on a contemporary technical architecture. Founded in 2015 in San Francisco, Canvas Medical targets independent primary care practices, direct primary care (DPC) practices, and value-based care organizations frustrated with legacy EHR systems.\n\nCanvas Medical's technical approach differs from legacy EHRs (Epic, athenahealth, eClinicalWorks) which were built in the early 2000s — Canvas uses a modern, API-first architecture that makes integration with third-party tools straightforward, and its workflow design reflects current clinical practice patterns rather than 1990s paper-chart workflows. The platform is particularly popular with DPC (direct primary care) practices that operate on membership subscription models, where the EHR needs to support high-touch patient communication and proactive care rather than just fee-for-service billing. Canvas also serves value-based care organizations where population health management tools matter.\n\nIn 2025, Canvas Medical competes with athenahealth, Modernizing Medicine, Elation Health, and DrChrono for ambulatory EHR market share in the primary care segment. The EHR market is mature but experiencing disruption pressure as smaller, newer entrants offer more modern experiences to independent practices that Legacy systems with dated UX can't match. The Canvas SDK allows developers to build custom workflow integrations, positioning Canvas as a platform rather than a closed system. The 2025 strategy focuses on growing with DSC and value-based care organizations scaling their primary care networks, deepening AI-powered clinical documentation (ambient note generation), and expanding the developer ecosystem built on Canvas's open API.
Precision birth control test using hormone and genetic data to personalize contraceptive selection; $2.65M from Lux Capital and M13 addressing trial-and-error that leaves millions on wrong contraceptives.
adyn is a precision medicine company developing personalized birth control solutions through at-home testing kits that analyze hormone levels and genetic risk factors — enabling individuals to choose hormonal contraceptives based on their own biology rather than trial-and-error, addressing a gap where most people cycle through multiple birth control options over years to find what works without causing intolerable side effects. Founded in 2019 and a Y Combinator graduate, adyn raised $2.65 million in seed funding co-led by Lux Capital and M13, with the Birth Control Optimization Test positioned as the first biology-based test for contraceptive personalization.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.